{"database": "lobbying", "table": "lobbying_activities", "rows": [[1627598, "b6df8468-c5cd-408c-bddc-b7c02b15566d", "Q4", "THE D MAJOR GROUP", 401103162, "CVS CAREMARK", 2014, "fourth_quarter", "PHA", "Issues concerning prescription drug abuse related to H.R. 3392, the \"Medicare Part D Patient Safety & Drug Abuse Prevention Act;\" H.R. 4069, the \"Ensuring Patient Access & Effective Drug Enforcement Act of 2014;\" and Protecting Integrity in Medicare Act (discussion draft).", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2015-01-17T16:07:05.247000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1627598"], "units": {}, "query_ms": 0.44503004755824804, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}